Combined Interleukin 1β/Interleukin 2 Treatment in Mice: Synergistic Myelostimulatory Activity and Protection against Cyclophosphamide-induced Myelosuppression (original) (raw)
Combined interleukin 1 beta/interleukin 2 treatment in mice: synergistic myelostimulatory activity and protection against cyclophosphamide-induced myelosuppression
Giampaolo Greco
Cancer research, 1993
View PDFchevron_right
Combined interleukin-1 beta/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression
Giampaolo Greco
Cancer research, 1994
View PDFchevron_right
Myelostimulatory activity of recombinant human interleukin-2 in mice
Dan Longo
Blood, 1989
View PDFchevron_right
Regulation of hemopoiesis in myelosuppressed mice by human recombinant IL-1 alpha
Nadine Tare
The Journal of Immunology
View PDFchevron_right
Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: Protection from hematological and nonhematological toxicities
Dan Longo
Cancer Research
View PDFchevron_right
In vivo interleukin-1 (IL-1) administration indirectly promotes type II IL-1 receptor expression on hematopoietic bone marrow cells: Novel mechanism for the hematopoietic effects of IL-1
K. Hestdal
Blood
View PDFchevron_right
Prevention of Acute Chemotherapy-induced Death in Mice by Recombinant Human Interleukin 1: Protection from Hematological and Nonhematological Toxicities1
Dan Longo
2000
View PDFchevron_right
Inhibition of interleukin-1β reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm
Shivam Rai
Nature Communications
View PDFchevron_right
Antibacterial resistance induced by recombinant interleukin 1 in myelosuppressed mice: Effect of treatment schedule and correlation with colony-stimulating activity in the bloodstream
Diana Boraschi
Cellular Immunology, 1990
View PDFchevron_right
Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation
Ruth Paulssen
Nature Communications, 2023
View PDFchevron_right
Production of interleukin-1 by bone marrow myeloma cells
Donatella Aldinucci
Blood, 1989
View PDFchevron_right
Targeting the interleukin-1 pathway in patients with hematological disorders
Mihai Netea
Blood, 2017
View PDFchevron_right
Report of a Phase I Evaluation of Dose and Schedule of Interleukin-1 Alpha and Cyclophosphamide in Patients with Advanced Tumors: An Eastern Cooperative Oncology Group Study (PX990) and Review of IL-1-Based Studies of Hematopoietic Reconstitution
William Tester
Journal of Interferon & Cytokine Research, 2014
View PDFchevron_right
Role of interleukin-1 in 4-hydroperoxycyclophosphamide toxicity to bone marrow progenitor cells: a review
Jan Moreb
Biotherapy (Dordrecht, Netherlands), 1989
View PDFchevron_right
Effect of M20 interleukin-1 inhibitor on normal and leukemic human myeloid progenitors
Eitan Fibach
Blood
View PDFchevron_right
Stimulation of hematopoiesis and antibacterial resistance by interleukin-1
Nadine Tare
Biotherapy, 1989
View PDFchevron_right
A two-part phase I trial of high-dose interleukin 2 in combination with soluble (Chinese hamster ovary) interleukin 1 receptor
mark klempner
Clinical cancer research : an official journal of the American Association for Cancer Research, 1998
View PDFchevron_right
Production of IL-1 by bone marrow myeloma cells
Donatella Aldinucci
Blood
View PDFchevron_right
Evaluating the Effects of Different Doses of Vitamin B2 and Single Dose of Vitamin B12 Against Myelosuppression Induced by Cyclophosphamide in Experimental Rats
Nada Al-Shawi
Iraqi Journal of Pharmaceutical Sciences ( P-ISSN: 1683 - 3597 , E-ISSN : 2521 - 3512), 2020
View PDFchevron_right
Interleukin-1 in the treatment of cancer
Brendan Curti
Pharmacology & Therapeutics, 1995
View PDFchevron_right
Inflammation-a Critical Appreciation of the Role of Myeloid Cells
David Greaves
Microbiology spectrum, 2016
View PDFchevron_right
Interleukin-1 beta (IL-1β) induces tumor necrosis factor alpha (TNF-α) expression on mouse myeloid multipotent cell line 32D cl3 and inhibits their proliferation
BENNY WEISS
Cytokine, 2004
View PDFchevron_right
Prevention of Doxorubicin-induced Hematotoxicity in Mice by Interleukin 1
Deborah Eppstein
Cancer Research, 1989
View PDFchevron_right
Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs: synergistic effects of doxorubicin and vincristine
Bruce Magun
Cancer biology & therapy, 2014
View PDFchevron_right
IL-1 and IL-1 Recruit Different Myeloid Cells and Promote Different Stages of Sterile Inflammation
O. Guttman, Y. Carmi
The Journal of Immunology, 2011
View PDFchevron_right
Interleukin-1 (IL-1) directly and indirectly promotes hematopoietic cell growth through type I IL-1 receptor
K. Hestdal
Blood, 1994
View PDFchevron_right
Interleukin 1 Enhances Growth Factor-Dependent Proliferation of the Clonogenic Cells in Acute Myeloblastic Leukemia and of Normal Human Primitive Hemopoietic Precursors
Trang Hoàng
2000
View PDFchevron_right